[stock_market_widget type="clock-markets" template="analog" timezone="America/New_York" title="New York" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/London" title="London" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/Brussels" title="Brussels" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Hong_Kong" title="Hong Kong" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Tokyo" title="Tokyo" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Australia/Sydney" title="Sydney" style="font-size: 7px; width: 100px;"]

Stock Market News

Illumina Falls 6% as CFO Leaves to Take Same Role at Quest Diagnostics

06/10/2022

Less than a minute

2022.06.10 00:11

Illumina Falls 6% as CFO Leaves to Take Same Role at Quest Diagnostics
Illumina (ILMN) Falls 6% as CFO Leaves to Take Same Role at Quest Diagnostics (DGX)

By Davit Kirakosyan

Illumina, Inc. (NASDAQ:ILMN) shares lost more than 6% after-hours after the company announced CFO Sam Samad will be departing the company on July 8, 2022, after serving in this role for more than five years.

Mr. Samad is leaving for Quest Diagnostics (NYSE:DGX), where he was named Executive Vice President and Chief Financial Officer.

Joydeep Goswami, the company’s Chief Strategy and Corporate Development Officer, will also serve as an interim CFO until a permanent CFO is appointed.

Source

06/10/2022

Less than a minute